The Swedish Study of Irrigation Fluid Temperature in the Evacuation of Chronic Subdural Hematoma (SIC!)

February 25, 2022 updated by: Andreas Bartley, Sahlgrenska University Hospital, Sweden

The Swedish Study of Irrigation Fluid Temperature in the Evacuation of Chronic Subdural Hematoma - A Multicenter Randomised Controlled Trial

The study will be a multicenter randomised controlled trial of the use of irrigation fluid of body temperature versus irrigation fluid of room temperature during burr hole evacuation of chronic subdural hematoma.

Study Overview

Study Type

Interventional

Enrollment (Actual)

588

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Göteborg, Sweden, 41345
        • Sahlgrenska Universtity Hospital, Department of neurosurgery, Sweden
      • Solna, Sweden, 17164
        • Karolinska University Hospital, Department of neurosurgery, Sweden
      • Uppsala, Sweden, 75309
        • Uppsala University Hospital, Department of neurosurgery, Sweden

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients with chronic subdural hematoma requiring burr hole evacuation.
  • Patients older than 18 years of age.

Exclusion Criteria:

  • Chronic subdural hematoma requiring surgical treatment other than burr hole evacuation.
  • Chronic subdural hematoma in a patient with an intracranial arachnoidal cyst.
  • Chronic subdural hematoma in a patient with a Cerebro Spinal Fluid-shunt.
  • Patients who have undergone intracranial surgery before.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: TRIPLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: Irrigation fluid of body temperature
During burr hole evacuation of the chronic subdural hematoma the irrigation fluid used will be of body temperature (approximately 37 degrees Celsius)
Irrigation fluid of body temperature will be used during burr hole evacuation of chronic subdural hematoma
ACTIVE_COMPARATOR: Irrigation fluid of room temperature
During burr hole evacuation of the chronic subdural hematoma the irrigation fluid used will be of room temperature (approximately 22 degrees Celsius)
Irrigation fluid of room temperature will be used during burr hole evacuation of chronic subdural hematoma.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Recurrence rate
Time Frame: 6 months
Recurrences requiring repeat surgery during a 6-month follow up period
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mortality
Time Frame: 6 months
The proportion deceased at a given time during the 6 month follow up.
6 months
Complications related to the surgery
Time Frame: 6 months
Complications will be assessed using the Landriel Ibanez classification modelThis model grades complications in 4 grades (Grade 1: no invasive treatment required; Grade 2: invasive treatment required, but not intensive care; Grade 3: invasive treatment required and intensive care; Grade 4: death).
6 months
Health related quality of life
Time Frame: 6 months
A standardised instrument, EuroQoL 5D-3L, will be used as a generic measure of health related quality of life. The questionnaire contains 5 questions in different domains.
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Asgeir Jakola, MD, PhD, Sahlgrenska University Hospital, Department of neurosurgery
  • Principal Investigator: Niklas Marklund, MD, Phd, Akademiska University Hospital, Department of neurosurgery
  • Principal Investigator: Jimmy Sundblom, MD, Phd, Akademiska University Hospital, Department of neurosurgery
  • Principal Investigator: Jiri Bartek, MD, Karolinska University Hospital, Department of neurosurgery
  • Principal Investigator: Andreas Bartley, MD, Sahlgrenska University Hospital, Department of neurosurgery
  • Study Director: Magnus Tisell, MD, PhD, Sahlgrenska Universtiy Hospital, Department of neurosurgery
  • Principal Investigator: Petter Förander, MD, PhD, Karolinska University Hospital, Department of neurosurgery

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2016

Primary Completion (ACTUAL)

October 1, 2020

Study Completion (ACTUAL)

October 20, 2020

Study Registration Dates

First Submitted

April 28, 2016

First Submitted That Met QC Criteria

April 28, 2016

First Posted (ESTIMATE)

May 2, 2016

Study Record Updates

Last Update Posted (ACTUAL)

February 28, 2022

Last Update Submitted That Met QC Criteria

February 25, 2022

Last Verified

February 1, 2022

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Subdural Hematoma

Clinical Trials on Irrigation fluid of body temperature

3
Subscribe